Stock Market Most Active AMEX Stocks Tuesday, November 26, 2013

New Post Public Reply Private Reply Replies (0) Message Board
Polgar
AMEX Most Active 

SYMBOL NAME PRICE ($) CHANGE % CHANGE VOLUME
SPY SPDR S&P 500 180.68 +0.05 +0.03%  26,850,644
EEM iShares MSCI Emerging Index Fund 41.53 +0.02 +0.05%  15,013,256
XLF SPDR Select Sector Fund - Financial 21.54 +0.02 +0.09%  13,758,823
EWJ iShares MSCI Japan Index Fund 12.02 -0.06 -0.46%  12,243,741
GDX Market Vectors Gold Miners ETF 21.69 -0.51 -2.30%  12,142,473
IWM iShares Russell 2000 ETF 112.39 +0.40 +0.36%  9,133,571
EFA iShares MSCI EAFE ETF 65.80 -0.15 -0.23%  6,085,930
VWO Vanguard FTSE Emerging Markets ETF 40.79 -0.06 -0.15%  5,561,394
IMUC Immunocellular Therapeutics 3.57 +0.07 +2.00%  5,303,277
TZA DIREXION DLY SM CAP BEAR 3X 18.84 -0.19 -1.01%  5,051,009
FXI iShares FTSE China 25 Index Fund 39.23 +0.06 +0.15%  4,951,640
EWZ iShares MSCI Brazil Capped Index Fund 47.10 -0.36 -0.76%  4,622,325
GLD SPDR Gold Trust 119.90 -0.56 -0.46%  4,227,842
XLU SPDR Select Sector Fund - Utilities 38.18 -0.33 -0.86%  4,044,866
NUGT Direxion Daily Gold Miners Bull 3X Shares 30.28 -2.28 -7.00%  3,119,085
XLE SPDR Select Sector Fund - Energy Select Sector 87.27 -0.16 -0.18%  3,099,508
TNA Direxion Small Cap Bull 3x Shares 72.40 +0.86 +1.20%  2,845,956
XIV VelocityShares Daily Inverse VIX Short Term ETN 33.46 +0.08 +0.24%  2,803,950
TLT iShares 20 Year Treasury Bond ETF 104.80 +0.59 +0.57%  2,717,610
ONVO Organovo Hldgs Inc 9.40 -0.19 -1.96%  2,560,109
XLI SPDR Select Sector Fund - Industrial 50.32 +0.08 +0.16%  2,532,993
IYR iShares U.S. Real Estate ETF 63.14 -0.09 -0.13%  2,461,236
ITB iShares U.S. Home Construction ETF 23.25 +0.67 +2.97%  2,406,957
TBT ProShares UltraShort Lehman 20 Year Treasury 76.14 -0.92 -1.19%  2,311,009
SLV iShares Silver Trust 19.13 -0.14 -0.73%  2,216,314
NGD New Gold Inc. 5.04 -0.17 -3.26%  2,184,392
OIH Market Vectors Oil Services ETF 48.50 -0.13 -0.27%  2,113,244
EWH iShares MSCI Hong Kong Index Fund 20.53 +0.11 +0.54%  2,062,833
SDS ProShares UltraShort S&P500 31.41 +0.01 +0.03%  1,972,406
UVXY ProShares Trust Ultra VIX Short Term Futures ETF 18.53 -0.10 -0.54%  1,956,771
XHB SPDR Series Trust SPDR Homebuilders ETF 31.96 +0.59 +1.88%  1,826,412
SSO ProShares Ultra S&P500 97.40 -0.07 -0.07%  1,819,725
EZU iShares MSCI EMU Index Fund 40.03 +0.12 +0.30%  1,818,772
XOP SPDR S&P Oil & Gas Explor & Product 68.86 +0.35 +0.51%  1,812,567
PLM Polymet Mining Corp. 1.20 +0.15 +14.10%  1,752,755
DUST Direxion Daily Gold Miners Bear 3X Shares 45.36 +3.10 +7.34%  1,660,965
TVIX VelocityShares Daily 2x VIX Short Term ETN 8.34 -0.06 -0.71%  1,567,336
SH ProShares Short S&P500 25.96 +0.01 +0.02%  1,546,210
XLK SPDR Select Sector Fund - Technology 34.24 +0.08 +0.23%  1,525,753
DXJ WisdomTree Japan Hedged Equity Fund 49.50 -0.21 -0.42%  1,513,821
UNG United States Natural Gas Fund LP 18.61 -0.17 -0.91%  1,510,252
IAU ishares Gold Trust 12.06 -0.06 -0.52%  1,466,907
FAZ Direxion Financial Bear 3X Shares 23.30 -0.05 -0.21%  1,450,005
UCO ProShares Ultra DJ-AIG Crude Oil 29.20 -0.35 -1.18%  1,446,163
XLV SPDR Select Sector Fund - Health Care 55.42 -0.06 -0.10%  1,442,195
DIA SPDR Dow Jones Industrial Average ETF 160.57 -0.04 -0.02%  1,392,431
QLD ProShares Ultra QQQ 91.24 +0.36 +0.40%  1,356,089
EWY iShares MSCI South Korea Capped Index Fund 63.87 +0.67 +1.06%  1,327,549
HYG iShares iBoxx $ High Yield Corporate Bond ETF 93.37 +0.06 +0.06%  1,288,627
FAS Direxion Financial Bull 3X Shares 84.63 +0.01 +0.01%  1,278,030
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 431

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 175

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 363

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 304

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 229

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 162

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 310

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 308

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 218

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading

Top 5 Most Recently Viewed Articles

Orion Corporation's Manager Transactions Highlight Executive Moves

Updated Category News Views 133

Understanding Orion Corporation's Executive Transactions Orion Corporation, a prominent player in the global pharmaceutical industry, has recently disclosed significant transactions involving its management, shedding light on financial movements that reflect company growth and strategy. Key Details on Managerial Transactions Recently, Orion Corporation reported under the...

Continue Reading
Congressman Questions SEC's 'Digital Asset Security' Definition

Updated Category News Views 150

Congressman Ritchie Torres Questions SEC's Use of Terminology Representative Ritchie Torres, a Democratic representative from New York, has recently shared his concerns about the phrase "digital asset security" as used by the U.S. Securities and Exchange Commission (SEC). He’s particularly interested in the legal basis and origins of this term. Congressional Dialogue...

Continue Reading
Investigating Claims for StubHub Investors: Your Options

Updated Category News Views 173

Investigation of Claims on Behalf of StubHub Investors Faruqi & Faruqi, LLP, a prominent name in national securities law, is currently looking into potential claims related to StubHub Holdings, Inc. (NYSE: STUB). This initiative aims to assist investors who might have faced losses due to the misleading statements made about the company's financial performance during its...

Continue Reading
Sarepta Therapeutics Faces Class Action Amid Safety Concerns

Updated Category News Views 256

Introduction to Sarepta Therapeutics Sarepta Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative therapies for rare diseases, particularly those associated with genetic factors. The company is well-known for its gene therapy treatments and aims to revolutionize treatment options for patients with Duchenne muscular dystrophy and similar...

Continue Reading